Pharming PHAR
NASDAQ PHAR
$9.75 -0.20 (-2.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pharming (PHAR) Return on Sales [ROS] (2020 - 2026)

Updated

Pharming (PHAR) reported Return on Sales [ROS] of -2.21% for Q2 2026, down 4.42 percentage points from 2.21% a year earlier but up 4.56 percentage points from the prior quarter.

Analysis

Pharming (PHAR) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Pharming's Return on Sales [ROS] came in at 2.20%, up 1.92 percentage points year-over-year; for FY2025, it came in at 6.87%, up 12.02 percentage points from FY2024.

  • Return on Sales [ROS] has a five-year change of -29.04 percentage points (FY2020 to FY2025).
  • By year, Return on Sales [ROS] came in at -5.15% in FY2024 (-2.95 pp), -2.20% in FY2023 (-16.01 pp), 13.81% in FY2022 (+13.81 pp) and 0.01% in FY2021 (-35.91 pp).
  • Five-year quarterly Return on Sales [ROS] spans a low of -26225371.12% in Q2 2024 and a high of 35.53% in Q2 2022.
  • Year over year, Return on Sales [ROS] gained in six of the last eight quarters, with an average year-over-year change of +3278176.16 percentage points.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q2 2025 (a gain of 26225373.33 percentage points); the low point was Q2 2024 (a drop of 26225380.77 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -6.77% (Q1 2026), 5.82% (Q4 2025) and 16.24% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Pharming 684.14 Mn -146.02 Mn 141.47 Mn -2.21%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.21%
Mar 31, 2026 -6.77%
Dec 31, 2025 5.82%
Sep 30, 2025 16.24%
Jun 30, 2025 2.21%
Mar 31, 2025 -8.85%
Dec 31, 2024 7.23%
Sep 30, 2024 5.48%
Jun 30, 2024 -26,225,371.12%
Mar 31, 2024 -29.32%
Dec 31, 2023 1.35%
Sep 30, 2023 2.86%
Jun 30, 2023 9.65%
Mar 31, 2023 -32.12%
Dec 31, 2022 -18.68%
Sep 30, 2022 14.39%
Jun 30, 2022 35.53%
Mar 31, 2022 6.01%
Dec 31, 2021 -10.01%
Sep 30, 2021 -3.19%
API Access

Pharming Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PHAR&period=max&api_key=YOUR_API_KEY